Crabbe1:3
|
|
|
ethanol
|
bal12
15403
dose (g/kg) control 1.0 1.2 1.4
|
inbred |
|
both |
8-16wks |
|
2003 |
| | |
|
|
Crabbe1:4
|
|
|
ethanol
|
bal15
15404
dose (g/kg): control 1.0 1.2 1.4
|
inbred |
|
both |
8-16wks |
|
2003 |
| | |
|
|
Crabbe1:5
|
|
|
ethanol
|
bal19
15405
dose (g/kg) control 1.0 1.2 1.4
|
inbred |
|
both |
8-16wks |
|
2003 |
| | |
|
|
Crabbe1:6
|
|
|
ethanol
|
grid_dist
15406
dose (g/kg): control 1.5 2.0 2.5
|
inbred |
|
both |
8-16wks |
|
2003 |
| | |
|
|
Crabbe1:7
|
|
|
ethanol
|
grid_ataxia
15407
dose (g/kg): control 1.5 2.0 2.5
|
inbred |
|
both |
8-16wks |
|
2003 |
| | |
|
|
Gould1:1
|
|
|
lithium
|
immob
37401
lithium dose [mg/kg]: 0(saline) 200 300 400
|
inbred |
|
m |
7-8wks |
|
2011 |
| | |
|
|
Gould1:5
|
|
|
lithium
|
blood_lithium
37405
lithium dose [mg/kg]: 200 300 400
|
inbred |
|
m |
7-8wks |
|
2011 |
| | |
|
|
Gould1:8
|
|
|
lithium
|
brain_lithium
37408
lithium dose [mg/kg]: 200 300 400
|
inbred |
|
m |
7-8wks |
|
2011 |
| | |
|
|
Gould2:17
|
|
|
nicotine
|
FC_immediate_acu
47131
dose (mg): control 0.045 0.09 0.18
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould2:21
|
|
|
nicotine
|
FC_context_acu
47136
dose (mg): control 0.045 0.09 0.18
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould2:25
|
|
|
nicotine
|
FC_preCS_acu
47141
dose (mg): control 0.045 0.09 0.18
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould2:29
|
|
|
nicotine
|
FC_CS_acu
47146
dose (mg) control 0.045 0.09 0.18
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:1
|
|
|
nicotine
|
grooming
47301
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:6
|
|
|
nicotine
|
scratching
47306
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:11
|
|
|
nicotine
|
jumping
47311
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:21
|
|
|
nicotine
|
EPM_pct_closed
47321
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:26
|
|
|
nicotine
|
EPM_pct_open
47326
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:31
|
|
|
nicotine
|
EPM_pct_center
47331
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:41
|
|
|
nicotine
|
FC_immediate
47341
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:46
|
|
|
nicotine
|
FC_context
47346
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:61
|
|
|
nicotine
|
FC_preCS
47361
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Gould3:66
|
|
|
nicotine
|
FC_CS
47366
control nicotine dose (mg) 3 6.3 12
|
inbred |
|
m |
8-12wks |
|
2011 |
| | |
|
|
Koide2:2
|
|
|
(none)
|
capsaicin
35802
concentration (µM): 0.5 1 4 7 10 15
|
wild-derived Mishima |
|
both |
8-12wks |
|
2003 |
| | |
|
|
Maurer1:1
|
|
|
atenolol, isoproterenol
|
pulse
33201
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:5
|
|
|
atenolol, isoproterenol
|
HR
33205
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:9
|
|
|
atenolol, isoproterenol
|
BP
33209
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:13
|
|
|
atenolol, isoproterenol
|
P_amp
33213
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:17
|
|
|
atenolol, isoproterenol
|
Q_amp
33217
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:21
|
|
|
atenolol, isoproterenol
|
R_amp
33221
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:25
|
|
|
atenolol, isoproterenol
|
S_amp
33225
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:29
|
|
|
atenolol, isoproterenol
|
P_dur
33229
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:33
|
|
|
atenolol, isoproterenol
|
PR
33233
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:37
|
|
|
atenolol, isoproterenol
|
RR
33237
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:41
|
|
|
atenolol, isoproterenol
|
QRS
33241
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:45
|
|
|
atenolol, isoproterenol
|
QT
33245
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:49
|
|
|
atenolol, isoproterenol
|
ST
33249
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:53
|
|
|
atenolol, isoproterenol
|
Parea
33253
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:57
|
|
|
atenolol, isoproterenol
|
QRSarea
33257
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:61
|
|
|
atenolol, isoproterenol
|
QTc_area
33261
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:66
|
|
|
atenolol, isoproterenol
|
bwchg
33266
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:70
|
|
|
atenolol, isoproterenol
|
heart_wt
33270
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:74
|
|
|
atenolol, isoproterenol
|
heart_adjwt
33274
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:78
|
|
|
atenolol, isoproterenol
|
atria_wt
33278
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:82
|
|
|
atenolol, isoproterenol
|
atria_adjwt
33282
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:86
|
|
|
atenolol, isoproterenol
|
ventr_wt
33286
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:90
|
|
|
atenolol, isoproterenol
|
ventr_adjwt
33290
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
Maurer1:94
|
|
|
atenolol, isoproterenol
|
atr_ventr
33294
control atenolol 10mg isoprot 1mg isoprot 10mg
|
inbred |
|
m |
7-13wks |
|
2009 |
| | |
|
|
McMullan6:1
|
|
|
(none)
|
bw_start
61501
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan6:6
|
|
|
exercise
|
bw_end
61506
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan6:11
|
|
|
exercise
|
bw_resp
61511
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan6:16
|
|
|
(none)
|
fat_start
61516
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan6:21
|
|
|
exercise
|
fat_end
61521
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan6:26
|
|
|
exercise
|
fat_resp
61526
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan6:31
|
|
|
(none)
|
lean_start
61531
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan6:36
|
|
|
exercise
|
lean_end
61536
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan6:41
|
|
|
exercise
|
lean_resp
61541
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:1
|
|
|
(none)
|
VO2_d_start
61601
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:4
|
|
|
exercise
|
VO2_d_end
61604
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:7
|
|
|
(none)
|
VO2_n_start
61607
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:11
|
|
|
exercise
|
VO2_n_end
61611
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:14
|
|
|
(none)
|
VCO2_d_start
61614
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:17
|
|
|
exercise
|
VCO2_d_end
61617
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:21
|
|
|
(none)
|
VCO2_n_start
61621
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:24
|
|
|
exercise
|
VCO2_n_end
61624
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:27
|
|
|
(none)
|
RER_d_start
61627
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:31
|
|
|
exercise
|
RER_d_end
61631
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:34
|
|
|
(none)
|
RER_n_start
61634
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:37
|
|
|
exercise
|
RER_n_end
61637
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:41
|
|
|
(none)
|
act_d_start
61641
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:44
|
|
|
exercise
|
act_d_end
61644
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:47
|
|
|
(none)
|
act_n_start
61647
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:51
|
|
|
exercise
|
act_n_end
61651
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:54
|
|
|
(none)
|
heat_d_start
61654
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:57
|
|
|
exercise
|
heat_d_end
61657
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:61
|
|
|
(none)
|
heat_n_start
61661
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:64
|
|
|
exercise
|
heat_n_end
61664
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:67
|
|
|
(none)
|
food_d_start
61667
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:71
|
|
|
exercise
|
food_d_end
61671
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:74
|
|
|
(none)
|
food_n_start
61674
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:77
|
|
|
exercise
|
food_n_end
61677
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:81
|
|
|
(none)
|
water_d_start
61681
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:84
|
|
|
exercise
|
water_d_end
61684
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:87
|
|
|
(none)
|
water_n_start
61687
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
McMullan7:91
|
|
|
exercise
|
water_n_end
61691
no exercise group moderate intensity group high intensity group
|
CC |
|
both |
8-10wks |
|
2018 |
| | |
|
|
Threadgill1:1
|
|
|
acetaminophen
|
liverwt
19401
dose (mg/kg): control 100 200 300
|
inbred w/CC7 |
|
m |
8-17wks |
|
2005 |
| | |
|
|
Threadgill1:4
|
|
|
acetaminophen
|
liver_necrosis
19404
dose (mg/kg): control 100 200 300
|
inbred w/CC7 |
|
m |
8-17wks |
|
2005 |
| | |
|
|
Threadgill1:10
|
|
|
acetaminophen
|
AST
19410
dose (mg/kg): control 100 200 300
|
inbred w/CC7 |
|
m |
8-17wks |
|
2005 |
| | |
|
|
Threadgill1:12
|
|
|
acetaminophen
|
BUN
19412
dose (mg/kg) control 100 200 300
|
inbred w/CC7 |
|
m |
8-17wks |
|
2005 |
| | |
|
|
Wiltshire4:1
|
|
|
BEZ235
|
Bcells_BEZ
52401
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:7
|
|
|
BEZ235
|
Tcells_BEZ
52407
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:13
|
|
|
BEZ235
|
monocytes_BEZ
52413
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:21
|
|
|
doxorubicin
|
Bcells_Dox
52421
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:27
|
|
|
doxorubicin
|
Tcells_Dox
52427
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:33
|
|
|
doxorubicin
|
monocytes_Dox
52433
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:41
|
|
|
idarubicin
|
Bcells_Ida
52441
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:47
|
|
|
idarubicin
|
Tcells_Ida
52447
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:53
|
|
|
idarubicin
|
monocytes_Ida
52453
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:61
|
|
|
selumetinib
|
Bcells_Sel
52461
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:67
|
|
|
selumetinib
|
Tcells_Sel
52467
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|
Wiltshire4:73
|
|
|
selumetinib
|
monocytes_Sel
52473
dose [µM]: control 0.046 0.137 1.235 11.1 100
|
inbred w/CC7 |
|
m |
10wks |
|
2015 |
| | |
|
|